s20098 has been researched along with Chemical and Drug Induced Liver Injury in 15 studies
*Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (93.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Qu, K; Wang, J; Wang, S; Xu, Q; Zhou, Z | 1 |
| Chirila, C; Collin, E; Deltour, N; Gutierrez, L; Hamm, L; Jacquot, E; Ladner, A; Perez-Gutthann, S; Tormos, A | 1 |
| Aguado, J; Brandt, L; Cainzos-Achirica, M; Castellsagué, J; Cortés, J; Deltour, N; Falissard, B; Forns, J; Giner-Soriano, M; Hägg, D; Hallas, J; Hellfritzsch, M; Jacquot, E; Morros, R; Perez-Gutthann, S; Perlemuter, G; Pladevall-Vila, M; Poblador-Plou, B; Pottegård, A; Prados-Torres, A; Reinders, T; Reutfors, J; Schink, T; Timmer, A | 1 |
| Štuhec, M | 1 |
| Aksak, S; Albayrak, A; Bayir, Y; Cadirci, E; Halici, Z; Karakus, E; Kiki, I; Polat, B; Topcu, A | 1 |
| Descalzi, VI; Fernández, MG; Gruz, F; Papale, RM; Raffa, S; Santucci, C; Videla, MG; Yantorno, S | 1 |
| Connemann, BJ; Freudenmann, RW; Gahr, M; Hiemke, C; Schönfeldt-Lecuona, C | 1 |
| Bagheri, H; Carvajal, A; Escudero, A; Falomir, T; Guerra, LN; Herdeiro, MT; Montastruc, F; Montastruc, JL; Sáinz, M; Scotto, S; Vaz, IR; Venegoni, M | 1 |
| Connemann, BJ; Fuchs, M; Gahr, M; Kratzer, W | 1 |
| Eder, P; Linke, K; Majewski, P; Permoda-Osip, A; Rybakowski, JK | 1 |
| Connemann, BJ; Gahr, M; Lang, D; Schönfeldt-Lecuona, C; Zeiss, R | 1 |
| Batailler, C; Cacoub, P; Guyader, D; Moore, K; Perlemuter, G; Saba, B; Valla, D | 1 |
| Howland, RH | 1 |
4 review(s) available for s20098 and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
CYP1A2 polymorphism may contribute to agomelatine-induced acute liver injury: Case report and review of the literature.
Topics: Acetamides; Aged; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP1A2; Humans; Hypnotics and Sedatives; Liver; Male; Polymorphism, Genetic | 2021 |
[Agomelatine: fulminant liver failure in a patient with fatty liver].
Topics: Acetamides; Aged; Antidepressive Agents; Causality; Chemical and Drug Induced Liver Injury; Contraindications; Depressive Disorder, Major; Female; Hepatic Encephalopathy; Humans; Inactivation, Metabolic; Liver; Liver Function Tests; Liver Transplantation; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease | 2014 |
Safety and tolerability of agomelatine: focus on hepatotoxicity.
Topics: Acetamides; Animals; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme System; Humans; Polymorphism, Genetic | 2014 |
Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients.
Topics: Acetamides; Adult; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Female; Humans; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Risk Factors; Transaminases | 2016 |
11 other study(ies) available for s20098 and Chemical and Drug Induced Liver Injury
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Agomelatine Drug Utilisation Study in Selected European Countries: A Multinational, Observational Study to Assess Effectiveness of Risk-Minimisation Measures.
Topics: Acetamides; Aged; Chemical and Drug Induced Liver Injury; Drug Utilization; Europe; Female; Humans; Hypnotics and Sedatives; Liver Function Tests; Male; Middle Aged; Risk Management; Treatment Outcome | 2019 |
Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data Sources.
Topics: Acetamides; Adolescent; Antidepressive Agents; Case-Control Studies; Chemical and Drug Induced Liver Injury; Depression; Depressive Disorder, Major; Europe; Female; Humans; Information Storage and Retrieval; Liver; Longitudinal Studies; Male; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2019 |
Agomelatine-induced hepatotoxicity.
Topics: Acetamides; Adult; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Humans; Hypnotics and Sedatives; Mood Disorders | 2013 |
Agomelatine: an antidepressant with new potent hepatoprotective effects on paracetamol-induced liver damage in rats.
Topics: Acetamides; Acetaminophen; Alanine Transaminase; Animals; Antidepressive Agents; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Dinoprost; Glutathione; Interleukin-6; Liver; Male; Protective Agents; Rats; Rats, Wistar; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2013 |
Agomelatine and hepatotoxicity: implications of cumulated data derived from spontaneous reports of adverse drug reactions.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Female; Germany; Humans; Male; Middle Aged; Risk Factors | 2013 |
Hepatotoxicity related to agomelatine and other new antidepressants: a case/noncase approach with information from the Portuguese, French, Spanish, and Italian pharmacovigilance systems.
Topics: Acetamides; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; France; Humans; Incidence; Italy; Pharmacovigilance; Portugal; Spain | 2014 |
Agomelatine-induced liver injury in a patient with choledocholithiasis.
Topics: Acetamides; Chemical and Drug Induced Liver Injury; Choledocholithiasis; Female; Humans; Hypnotics and Sedatives; Middle Aged | 2015 |
Hepatotoxicity associated with agomelatine and other antidepressants: Disproportionality analysis using pooled pharmacovigilance data from the Uppsala Monitoring Centre.
Topics: Acetamides; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Humans; Pharmacovigilance; Sweden | 2015 |
Agomelatine: to be avoided, with or without a "patient booklet".
Topics: Acetamides; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Humans; Pamphlets | 2015 |
Publication bias and outcome reporting bias: agomelatine as a case example.
Topics: Acetamides; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Humans; Publication Bias; Sexual Dysfunction, Physiological; Sleep Wake Disorders | 2011 |